FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...
Averra Packaging today announced the completion of a significant clean room expansion project. This expansion doubles the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback